The Global Pharmaceutical Regulatory Affairs Summit 2024 is set to convene in Brussels from October 22nd to 24th at the Sheraton Brussels Airport. This premier event brings together regulatory authorities, industry leaders, and regulatory affairs professionals for a three-day hybrid conference focused on the latest trends, tools, and strategies shaping the global pharmaceutical landscape.
With the ever-evolving regulatory environment, this summit provides an invaluable platform for professionals to engage with the most pressing issues in the field. Attendees can expect to gain insights into the latest guidance on pharmaceutical legislation, IDMP implementation, regulatory information management, and data initiatives. The agenda is meticulously curated to address key topics such as:
- A Deeper Look: The Revision of European Pharmaceutical Regulation
- Multi-Stakeholder Perspective: Defining Gene Therapy Medicinal Product (GTMP)
- Electronic Application Forms (eAF): Integration with the Target Operating Model
- International Update: Global Substance Registration System (G-SRS)
- Multi-Stakeholder Panel: The Future of RIMs
- eCTD in Europe: Current Status and Future Prospects
- Industry Perspective: Structured Content Authoring
- Global Markets and Reliance: Current Developments
- Reliance in MENA: Latest Insights
This year’s summit boasts an impressive lineup of speakers, including key figures from global regulatory bodies and industry leaders:
- Isabel Chicharo, Head of Regulatory Data Management Service at the European Medicines Agency (EMA), will share her expertise on regulatory data management and its implications for pharmaceutical companies.
- Mustafa Ghafouri, Lead Data Architect at the Medicines and Healthcare Products Regulatory Agency (MHRA), will delve into the intricacies of data architecture in regulatory processes.
- Shannon Laforce, Executive Director of Transformation and Business Informatics at Health Canada, will discuss the agency’s approach to digital transformation and its impact on regulatory affairs.
- Larry Callahan, a Chemist at the FDA, will provide insights into the FDA’s regulatory strategies and their global implications.
- Nawaf Almutairi, a Regulatory Affairs Expert at the Saudi Food and Drug Authority, will discuss the latest regulatory developments in the MENA region.
- Khalid Al-Kinani, Head of the Biologics and Biosimilars Registration Committee at the Iraqi Ministry of Health, will offer perspectives on biologics and biosimilars regulation.
- Faraat Ali, Manager of the Department of Inspection and Enforcement at the Botswana Medicines Regulatory Authority (BOMRA), will share his experiences in enforcement and laboratory services.
- Remco Munnik, Vice President of the IRISS Forum, will explore the future of RIM systems and their role in the regulatory landscape.
This summit promises to be a transformative experience for all participants, offering a unique opportunity to engage with the thought leaders and innovators who are shaping the future of pharmaceutical regulation.
For those interested in attending, be sure to use the exclusive promo code GPRASPM24 to save 15% off your registration. This offer cannot be combined with other promotions and restrictions may apply. Don’t miss out on this chance to secure your spot at the forefront of regulatory affairs.
View the full agenda and register today to ensure your participation in this essential industry event.
See you in Brussels!